Copyright Reports & Markets. All rights reserved.

Global Gabapentin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Gabapentin Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Capsule
    • 1.3.3 Tablet
    • 1.3.4 Injection
  • 1.4 Market Analysis by Therapeutic Indication
    • 1.4.1 Overview: Global Gabapentin Consumption Value by Therapeutic Indication: 2021 Versus 2025 Versus 2032
    • 1.4.2 Epilepsy
    • 1.4.3 Neuropathic Pain
    • 1.4.4 Restless Legs Syndrome
    • 1.4.5 Others
  • 1.5 Market Analysis by Product Type
    • 1.5.1 Overview: Global Gabapentin Consumption Value by Product Type: 2021 Versus 2025 Versus 2032
    • 1.5.2 Branded Gabapentin
    • 1.5.3 Generic Gabapentin
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Gabapentin Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Hospital
    • 1.6.3 Retail Pharmacy
  • 1.7 Global Gabapentin Market Size & Forecast
    • 1.7.1 Global Gabapentin Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Gabapentin Sales Quantity (2021-2032)
    • 1.7.3 Global Gabapentin Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Gabapentin Product and Services
    • 2.1.4 Pfizer Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 Depomed
    • 2.2.1 Depomed Details
    • 2.2.2 Depomed Major Business
    • 2.2.3 Depomed Gabapentin Product and Services
    • 2.2.4 Depomed Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Depomed Recent Developments/Updates
  • 2.3 TEVA
    • 2.3.1 TEVA Details
    • 2.3.2 TEVA Major Business
    • 2.3.3 TEVA Gabapentin Product and Services
    • 2.3.4 TEVA Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 TEVA Recent Developments/Updates
  • 2.4 Viatris
    • 2.4.1 Viatris Details
    • 2.4.2 Viatris Major Business
    • 2.4.3 Viatris Gabapentin Product and Services
    • 2.4.4 Viatris Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Viatris Recent Developments/Updates
  • 2.5 Alvogen
    • 2.5.1 Alvogen Details
    • 2.5.2 Alvogen Major Business
    • 2.5.3 Alvogen Gabapentin Product and Services
    • 2.5.4 Alvogen Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Alvogen Recent Developments/Updates
  • 2.6 Novartis
    • 2.6.1 Novartis Details
    • 2.6.2 Novartis Major Business
    • 2.6.3 Novartis Gabapentin Product and Services
    • 2.6.4 Novartis Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Novartis Recent Developments/Updates
  • 2.7 Apotex
    • 2.7.1 Apotex Details
    • 2.7.2 Apotex Major Business
    • 2.7.3 Apotex Gabapentin Product and Services
    • 2.7.4 Apotex Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Apotex Recent Developments/Updates
  • 2.8 Sun Pharmaceutical
    • 2.8.1 Sun Pharmaceutical Details
    • 2.8.2 Sun Pharmaceutical Major Business
    • 2.8.3 Sun Pharmaceutical Gabapentin Product and Services
    • 2.8.4 Sun Pharmaceutical Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Sun Pharmaceutical Recent Developments/Updates
  • 2.9 Aurobindo Pharma
    • 2.9.1 Aurobindo Pharma Details
    • 2.9.2 Aurobindo Pharma Major Business
    • 2.9.3 Aurobindo Pharma Gabapentin Product and Services
    • 2.9.4 Aurobindo Pharma Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Aurobindo Pharma Recent Developments/Updates
  • 2.10 Intas
    • 2.10.1 Intas Details
    • 2.10.2 Intas Major Business
    • 2.10.3 Intas Gabapentin Product and Services
    • 2.10.4 Intas Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Intas Recent Developments/Updates
  • 2.11 Amneal
    • 2.11.1 Amneal Details
    • 2.11.2 Amneal Major Business
    • 2.11.3 Amneal Gabapentin Product and Services
    • 2.11.4 Amneal Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Amneal Recent Developments/Updates
  • 2.12 Marksans Pharma
    • 2.12.1 Marksans Pharma Details
    • 2.12.2 Marksans Pharma Major Business
    • 2.12.3 Marksans Pharma Gabapentin Product and Services
    • 2.12.4 Marksans Pharma Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Marksans Pharma Recent Developments/Updates
  • 2.13 Glenmark
    • 2.13.1 Glenmark Details
    • 2.13.2 Glenmark Major Business
    • 2.13.3 Glenmark Gabapentin Product and Services
    • 2.13.4 Glenmark Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Glenmark Recent Developments/Updates
  • 2.14 Alkem
    • 2.14.1 Alkem Details
    • 2.14.2 Alkem Major Business
    • 2.14.3 Alkem Gabapentin Product and Services
    • 2.14.4 Alkem Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Alkem Recent Developments/Updates
  • 2.15 Jiangsu Enhua
    • 2.15.1 Jiangsu Enhua Details
    • 2.15.2 Jiangsu Enhua Major Business
    • 2.15.3 Jiangsu Enhua Gabapentin Product and Services
    • 2.15.4 Jiangsu Enhua Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Jiangsu Enhua Recent Developments/Updates
  • 2.16 Jiangsu Hengrui
    • 2.16.1 Jiangsu Hengrui Details
    • 2.16.2 Jiangsu Hengrui Major Business
    • 2.16.3 Jiangsu Hengrui Gabapentin Product and Services
    • 2.16.4 Jiangsu Hengrui Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Jiangsu Hengrui Recent Developments/Updates
  • 2.17 Sailike
    • 2.17.1 Sailike Details
    • 2.17.2 Sailike Major Business
    • 2.17.3 Sailike Gabapentin Product and Services
    • 2.17.4 Sailike Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Sailike Recent Developments/Updates

3 Competitive Environment: Gabapentin by Manufacturer

  • 3.1 Global Gabapentin Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Gabapentin Revenue by Manufacturer (2021-2026)
  • 3.3 Global Gabapentin Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Gabapentin by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Gabapentin Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Gabapentin Manufacturer Market Share in 2025
  • 3.5 Gabapentin Market: Overall Company Footprint Analysis
    • 3.5.1 Gabapentin Market: Region Footprint
    • 3.5.2 Gabapentin Market: Company Product Type Footprint
    • 3.5.3 Gabapentin Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Gabapentin Market Size by Region
    • 4.1.1 Global Gabapentin Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Gabapentin Consumption Value by Region (2021-2032)
    • 4.1.3 Global Gabapentin Average Price by Region (2021-2032)
  • 4.2 North America Gabapentin Consumption Value (2021-2032)
  • 4.3 Europe Gabapentin Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Gabapentin Consumption Value (2021-2032)
  • 4.5 South America Gabapentin Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Gabapentin Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Gabapentin Sales Quantity by Type (2021-2032)
  • 5.2 Global Gabapentin Consumption Value by Type (2021-2032)
  • 5.3 Global Gabapentin Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Gabapentin Sales Quantity by Application (2021-2032)
  • 6.2 Global Gabapentin Consumption Value by Application (2021-2032)
  • 6.3 Global Gabapentin Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Gabapentin Sales Quantity by Type (2021-2032)
  • 7.2 North America Gabapentin Sales Quantity by Application (2021-2032)
  • 7.3 North America Gabapentin Market Size by Country
    • 7.3.1 North America Gabapentin Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Gabapentin Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Gabapentin Sales Quantity by Type (2021-2032)
  • 8.2 Europe Gabapentin Sales Quantity by Application (2021-2032)
  • 8.3 Europe Gabapentin Market Size by Country
    • 8.3.1 Europe Gabapentin Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Gabapentin Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Gabapentin Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Gabapentin Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Gabapentin Market Size by Region
    • 9.3.1 Asia-Pacific Gabapentin Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Gabapentin Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Gabapentin Sales Quantity by Type (2021-2032)
  • 10.2 South America Gabapentin Sales Quantity by Application (2021-2032)
  • 10.3 South America Gabapentin Market Size by Country
    • 10.3.1 South America Gabapentin Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Gabapentin Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Gabapentin Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Gabapentin Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Gabapentin Market Size by Country
    • 11.3.1 Middle East & Africa Gabapentin Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Gabapentin Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Gabapentin Market Drivers
  • 12.2 Gabapentin Market Restraints
  • 12.3 Gabapentin Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Gabapentin and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Gabapentin
  • 13.3 Gabapentin Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Gabapentin Typical Distributors
  • 14.3 Gabapentin Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Gabapentin market size was valued at US$ 1516 million in 2025 and is forecast to a readjusted size of US$ 1894 million by 2032 with a CAGR of 3.3% during review period.
    Gabapentin is a structural analog of gamma-aminobutyric acid (GABA), originally developed for the treatment of partial seizures and now widely prescribed for neuropathic pain, restless legs syndrome, anxiety disorders, and alcohol withdrawal. Its primary mechanism involves modulating the α2-δ subunit of voltage-gated calcium channels to reduce neuronal excitability, achieving both antiepileptic and analgesic effects. With favorable safety and low drug interaction profiles, Gabapentin is widely adopted in the management of chronic neuropathic conditions. As the prevalence of chronic pain and neuropsychiatric disorders continues to rise, Gabapentin’s market has evolved from a single-prescription segment into a diversified field encompassing combination therapies, extended-release formulations, and generics—positioning it as one of the most resilient categories within the global CNS therapeutics landscape.In 2024, global Gabapentin production reached approximately 12941 m units, with an average global market price of around US$ 0.11 perunit.The average gross profit margin of this product is 45%.
    The global Gabapentin market is undergoing structural expansion. Rising incidences of chronic pain, postherpetic neuralgia, and diabetic neuropathy continue to drive prescription growth. Government initiatives to strengthen pain management systems and restrict opioid use have created favorable conditions for non-addictive analgesics such as Gabapentin. Meanwhile, the growing penetration of generics and the introduction of extended-release formulations are reshaping product portfolios, allowing continued growth in mature markets. Major pharmaceutical companies are investing in novel prodrugs like Gabapentin enacarbil and combination therapies to extend product lifecycles and enhance market differentiation.
    Despite solid demand, the market faces dual challenges of pricing pressure and stricter prescription control. Several countries have reclassified Gabapentin as a controlled substance due to increasing abuse potential. Intense generic competition compresses brand profit margins, while innovative formulations require higher R&D and regulatory costs. Moreover, the concentration of API suppliers makes the industry vulnerable to raw material fluctuations and trade policy shifts, potentially impacting cost structures.
    Clinical demand for Gabapentin is diversifying beyond traditional epilepsy and neuropathic pain indications. The drug is increasingly used in anxiety, sleep disorders, and withdrawal management. Prescription patterns are shifting from specialist-driven to primary care and chronic disease management. Rapid growth of digital prescriptions and online pharmacy channels is improving accessibility, transforming the market from prescription-dependent to patient-driven consumption.
    Gabapentin synthesis primarily relies on intermediates such as cyclohexylamine and γ-butyrolactone. Production is largely based on chemical synthesis, though some firms are adopting biocatalytic approaches to improve sustainability. Stricter environmental regulations and fluctuating trade costs contribute to raw material price volatility. With Asia—particularly China and India—emerging as key API suppliers, integrated supply chain strategies have become a core competitive edge for leading manufacturers.
    This report is a detailed and comprehensive analysis for global Gabapentin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Gabapentin market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
    Global Gabapentin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
    Global Gabapentin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
    Global Gabapentin market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Gabapentin
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Gabapentin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Depomed, TEVA, Viatris, Alvogen, Novartis, Apotex, Sun Pharmaceutical, Aurobindo Pharma, Intas, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Gabapentin market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Capsule
    Tablet
    Injection
    Market segment by Therapeutic Indication
    Epilepsy
    Neuropathic Pain
    Restless Legs Syndrome
    Others
    Market segment by Product Type
    Branded Gabapentin
    Generic Gabapentin
    Market segment by Application
    Hospital
    Retail Pharmacy
    Major players covered
    Pfizer
    Depomed
    TEVA
    Viatris
    Alvogen
    Novartis
    Apotex
    Sun Pharmaceutical
    Aurobindo Pharma
    Intas
    Amneal
    Marksans Pharma
    Glenmark
    Alkem
    Jiangsu Enhua
    Jiangsu Hengrui
    Sailike
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Gabapentin product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Gabapentin, with price, sales quantity, revenue, and global market share of Gabapentin from 2021 to 2026.
    Chapter 3, the Gabapentin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Gabapentin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Gabapentin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Gabapentin.
    Chapter 14 and 15, to describe Gabapentin sales channel, distributors, customers, research findings and conclusion.

    Buy now